Selected Grants
ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas
ResearchCollaborator · Awarded by National Cancer Institute · 2022 - 2027PRECLINICAL THERAPEUTIC SCREENING FOR NEW THERAPIES FOR GLIOBLASTOMA MULTIFORME
ResearchInvestigator · Awarded by Jewish Communal Fund · 2022 - 2026Evaluation of Cannabinoid Therapeutics in Brain Tumor Xenografts
ResearchPrincipal Investigator · Awarded by Diverse Biotech · 2024 - 2025The role of SMARCAL1 in glioma telomere maintenance.
ResearchCollaborator · Awarded by National Cancer Institute · 2022 - 2025Evaluation of Cannabinoid Therapeutics in Brain Tumor Xenografts
ResearchPrincipal Investigator · Awarded by Diverse Biotech · 2021 - 2023Oncolytic Viral Therapy in Brain Tumor Setting
ResearchPrincipal Investigator · Awarded by ImmVira Pharma Co., Ltd. · 2020 - 2022Patient Avatars for Pediatric Brain Tumors
ResearchCo Investigator · Awarded by Ian's Friends Foundation · 2020 - 2021Evaluation of Panobinostat in Patient Derived Adult IDH1 Mutated Brain Tumor Xenografts
ResearchPrincipal Investigator · Awarded by Midatech Pharma Plc · 2018 - 2020Assessment of ST101 in Glioblastoma
ResearchPrincipal Investigator · Awarded by Sapience Therapeutics Inc. · 2018 - 2020Pediatric Brain Tumor Consortium
Clinical TrialCollaborator · Awarded by St. Jude Children's Research Hospital · 2014 - 2017Truncated GLI1 In Glioblastoma
ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2014Regional AGT Depletion of CNS and Leptomeningeal Tumors
ResearchResearch Analyst · Awarded by National Institutes of Health · 2002 - 2006Fellowships, Gifts, and Supported Research
Evaluation of Ipatasertib in Pediatric HGG ·
October 2018
- September 2019
PI ·
Awarded by: F.Hoffman-La Roche LDS
Assessment of ST101 in GBM ·
August 2018
- February 2020
PI ·
Awarded by: Sapience Therapeutics Inc
Evaluation of Panobinostat in Patient Derived Adult IDH1 Mutated Brain Tumor Xenografts ·
May 2018
- May 2019
PI ·
Awarded by: Midatech Pharma Plc